Biochemical and Cellular Mechanisms of Toxic Liver Injury

 

 Buy Article Permissions and Reprints

ABSTRACT

The pathogenesis of drug- or toxin-induced liver injury usually involves the participation of toxic metabolites that either elicit an immune response or directly affect the biochemistry of the cell. The clinical appearance of hepatitis is then a consequence of cell death mediated by either the extrinsic immune system (e.g., cytotoxic T cells) or intracellular stress. Intracellular stress can lead to apoptotic or necrotic cell death, depending on the extent of mitochondrial involvement and the balance of factors that activate and inhibit the Bcl₂ family of proteins and the caspases. Drug metabolites can undergo or promote a variety of chemical reactions, including covalent binding, depletion of reduced glutathione, or oxidative stress with consequent effects on proteins, lipids, and DNA. These chemical consequences can directly affect organelles such as mitochondria, cytoskeleton, endoplasmic reticulum, microtubules, or nucleus or indirectly influence these organelles through activation or inhibition of signaling kinases, transcription factors, and gene expression profiles. The outcome may be either triggering of the necrotic or apoptotic process or sensitization to the lethal action of cytokines of the immune system intrinsic to the liver.

REFERENCES

• 1 Zimmerman H. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver, 2nd ed. Philadelphia. Lippincott Williams & Wilkins 1999
  Google Scholar
• 2 Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation.  Drug Saf . 2001;  24 483-490
  PubMedGoogle Scholar
• 3 Kaplowitz N. Cell death at the millennium: implications for liver diseases.  Clin Liver Dis . 2000;  4 1-23
  PubMedGoogle Scholar
• 4 Kaplowitz N. Mechanisms of liver cell injury.  J Hepatol . 2000;  32 39-47
  PubMedGoogle Scholar
• 5 Robin M, LeRoy M, Descatoire V, Pessayre D. Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis.  J Hepatol . 1997;  26 23-30
  CrossrefPubMedGoogle Scholar
• 6 Liu Z-X, Kaplowitz N. Immune-mediated drug-induced liver disease (in press).  Clin Liver Dis.
  PubMedGoogle Scholar
• 7 Kaplowitz N. Mechanisms of cell death and relevance to drug hepatotoxicity. In: Kaplowitz N, DeLeve L, eds. Drug Hepatotoxicity New York: Marcel Dekker (in press)
  Google Scholar
• 8 Thornberry N A, Lazebnik Y. Caspase: enemies within.  Science . 1998;  281 1312-1316
  CrossrefPubMedGoogle Scholar
• 9 Leist M, Single B, Castoldi A F. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis.  J Exp Med . 1997;  185 1481-1486
  CrossrefPubMedGoogle Scholar
• 10 Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis and autolytic cell death.  Hepatology . 1995;  21 1465-1468
  CrossrefPubMedGoogle Scholar
• 11 Dong Z, Saikumar P, Weinberg J, Venkatachalam M. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death.  Am J Pathol . 1997;  151 1205-1213
  PubMedGoogle Scholar
• 12 Ashkenazi A, Dixit V. Death receptors: signaling and modulation.  Science . 1998;  281 1305-1308
  CrossrefPubMedGoogle Scholar
• 13 Faubion W A, Gores G. Death receptors in liver biology and pathology.  Hepatology . 1999;  29 1-4
  CrossrefPubMedGoogle Scholar
• 14 Wei M C, Zong W X, Cheng E. Pro-apoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.  Science . 2001;  292 727-730
  CrossrefPubMedGoogle Scholar
• 15 Puthalakath H, Villunger A, O'Reilly L A. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis.  Science . 2001;  293 1829-1832
  CrossrefPubMedGoogle Scholar
• 16 Kyriakis J, Banerjee P, Nilolakaki E. The stress-activated protein kinase subfamily of c-Jun kinases.  Nature . 1994;  369 156-160
  CrossrefPubMedGoogle Scholar
• 17 Zamzani N, Marzo I, Susin S. Thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition.  Oncogene . 1998;  16 1055-1063
  CrossrefPubMedGoogle Scholar
• 18 Slee E A, Adrain C, Martin S J. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis.  J Biol Chem . 2001;  276 7320-7326
  CrossrefPubMedGoogle Scholar
• 19 Susin S, Lorenzo H, Zamzani N. Molecular characterization of mitochondrial apoptosis-inducing factor.  Nature . 1999;  397 441-446
  CrossrefPubMedGoogle Scholar
• 20 Lorenzo H K, Susin S A, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death.  Cell Death Differ . 1999;  6 516-524
  CrossrefPubMedGoogle Scholar
• 21 Rao R V, Hermel E, Castro-Obregon S. Coupling endoplasmic reticulum stress to the cell death program: mechanism of caspase activation.  J Biol Chem . 2001;  276 33869-33874
  CrossrefPubMedGoogle Scholar
• 22 Kim Y-M, Talanian R V, Billiar T R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms.  J Biol Chem . 1997;  272 31138-31148
  CrossrefPubMedGoogle Scholar
• 23 Hampton M B, Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis.  FEBS Lett . 1997;  414 552-556
  CrossrefPubMedGoogle Scholar
• 24 Hentze H, Kunstle G, Volbracht C. CD95-mediated murine hepatic apoptosis requires an intact glutathione status.  Hepatology . 1999;  30 177-185
  CrossrefPubMedGoogle Scholar
• 25 Goyal L. Cell death inhibition: keeping caspases in check.  Cell . 2001;  104 805-808
  CrossrefPubMedGoogle Scholar
• 26 Masser D D, Antoine C, Bourget L. Role of the human heat shock protein hsp 70 in protection against stress-induced apoptosis.  Mol Cell Biol . 1997;  17 5317-5327
  PubMedGoogle Scholar
• 27 Hu S, Vincenz C, Ni J. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis.  J Biol Chem . 1997;  272 17255-17257
  CrossrefPubMedGoogle Scholar
• 28 Adams J M, Cory S. The Bcl-2 protein family: arbiters of cell survival.  Science . 1998;  281 1322-1326
  CrossrefPubMedGoogle Scholar
• 29 Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis.  Nat Med . 1997;  3 614-620
  CrossrefPubMedGoogle Scholar
• 30 Rust C, Karnitz L M, Paya C V. The bile acid tauroursodeoxycholate activates a phosphatidylinositol 3-kinase dependent survival signaling cascade.  J Biol Chem . 2000;  275 20210-20216
  CrossrefPubMedGoogle Scholar
• 31 Aggarwal B. Apoptosis and nuclear factor-κB: a tale of association and dissociation.  Biochem Pharmacol . 2000;  60 1033-1039
  CrossrefPubMedGoogle Scholar
• 32 Wang C Y, Mayo M W, Korneluk R G. NF-κB antiapoptosis: induction of TRAF1 and C-IAP1 and c-IAP2 to suppress caspase-8 activation.  Science . 1998;  281 1680-1683
  CrossrefPubMedGoogle Scholar
• 33 Czaja M, Xu J, Alt E. Prevention of carbon tetrachloride- induced rat liver injury by soluble tumor necrosis factor receptor.  Gastroenterology . 1995;  108 1849-1854
  PubMedGoogle Scholar
• 34 Morio L A, Chiu H, Sprowles K A. Distinct roles of tumor necrosis factor-α and nitric oxide in acute liver injury induced by carbon tetrachloride in mice.  Toxicol Appl Pharmacol . 2001;  172 44-51
  CrossrefPubMedGoogle Scholar
• 35 Laskin D L, Gardner C R, Price V F, Jollow D J. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen.  Hepatology . 1995;  21 1045-1050
  CrossrefPubMedGoogle Scholar
• 36 Boess F, Bopst M, Althaus R. Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-α gene knockout mice.  Hepatology . 1998;  27 1021-1029
  CrossrefPubMedGoogle Scholar
• 37 Hogaboam C M, Bone-Lasron C L, Steinhauser M L. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking c-c chemokine receptor 2.  Am J Pathol . 2000;  156 1245-1252
  PubMedGoogle Scholar
• 38 Iimuro Y, Nishiura T, Hellerbrand C. NFκB prevents apoptosis and liver dysfunction during liver regeneration.  J Clin Invest . 1998;  101 802-811
  PubMedGoogle Scholar
• 39 Leist M, Gantner F, Naumann H. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins.  Gastroenterology . 1997;  112 923-934
  PubMedGoogle Scholar
• 40 Haouzi D, Lekehal M, Tinel M. Prolonged, but not acute, glutathione depletion promotes Fas-mediated mitochondrial permeability transition and apoptosis in mice.  Hepatology . 2001;  33 1181-1188
  CrossrefPubMedGoogle Scholar
• 41 Goosens V, Grooten J, DeVos K, Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity.  Proc Natl Acad Sci USA . 1995;  92 8115-8119
  PubMedGoogle Scholar
• 42 Colell A, Garcia-Ruiz C, Miranda M. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor.  Gastroenterology . 1998;  115 1541-1551
  PubMedGoogle Scholar
• 43 Colell A, Coll O, Garcia-Ruiz C. Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against TNF-induced cell death by replenishing mitochondrial GSH.  Hepatology . 2001;  34 964-971
  CrossrefPubMedGoogle Scholar
• 44 Garcia-Ruiz C, Colell A, Paris R, Fernandez-Checa J C. Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release and caspase activation.  FASEB J . 2000;  14 847-858
  PubMedGoogle Scholar
• 45 Sithoh M, Nishitoh H, Fuju M. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK)-1.  EMBO J . 1998;  17 2596-1206
  CrossrefPubMedGoogle Scholar
• 46 Adler V, Yin Z, Fuchs S. Regulation of JNK by GSTpi.  EMBO J . 1999;  18 1321-1334
  CrossrefPubMedGoogle Scholar
• 47 Ginne-Pease M E, Whisler R L. Optimal NF-κB mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals.  Biochem Biophys Res Commun . 1996;  226 695-702
  CrossrefPubMedGoogle Scholar
• 48 Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease.  Prog Liver Dis . 1996;  14 131-159
  PubMedGoogle Scholar
• 49 Adamson G, Harman A. Oxidative stress in cultured hepatocytes exposed to acetaminophen.  Biochem Pharmacol . 1993;  45 2289-2294
  CrossrefPubMedGoogle Scholar
• 50 Arnaiz S, Llesuy S, Cutrin J, Boveris A. Oxidative stress by acute acetaminophen administration in mouse liver.  Free Radic Biol Med . 1995;  19 303-310
  CrossrefPubMedGoogle Scholar
• 51 Sneed R A, Buchweitz J P, Jean P A, Ganey P E. Pentoxifylline attenuates bacterial lipopolysaccharide-induced enhancement of allyl alcohol hepatotoxicity.  Toxicol Sci . 2000;  56 203-210
  CrossrefPubMedGoogle Scholar
• 52 Berson A, DeBeco V, Letteron P. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes.  Gastroenterology . 1998;  114 764-774
  PubMedGoogle Scholar
• 53 Feng G, Kaplowitz N. Colchicine protects mice from the lethal effect of agonistic anti-Fas antibody.  J Clin Invest . 2000;  105 329-339
  PubMedGoogle Scholar
• 54 Botla R, Spivey J, Aguilar H. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.  J Pharmacol Exp Ther . 1995;  272 930-938
  PubMedGoogle Scholar
• 55 Rodrigues C MP, Fan G, Ma X. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.  J Clin Invest . 1998;  101 2790-2799
  CrossrefPubMedGoogle Scholar
• 56 Kovalovich K, Li W, DeAngelis R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.  J Biol Chem . 2001;  276 26605-26613
  CrossrefPubMedGoogle Scholar
• 57 Lemasters J J. Mechanisms of hepatic toxicity v.  necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol . 1999;  276 G1-G6
  PubMedGoogle Scholar
• 58 Lemaire C, Andreau K, Souvannavong V. Inhibition of caspase induces a switch from apoptosis to necrosis.  FEBS Lett . 1998;  425 266-270
  CrossrefPubMedGoogle Scholar